Literature DB >> 13700943

Clinical experience with norethisterone and norethisterone acetate.

G L FOSS.   

Abstract

Entities:  

Keywords:  GYNECOLOGY/therapy; PROGESTERONE/related compounds

Mesh:

Substances:

Year:  1960        PMID: 13700943      PMCID: PMC2096981          DOI: 10.1136/bmj.2.5207.1187

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Determination of the relative potency of some progestogens in the human.

Authors:  G I SWYER; L SEBOK; D F BARNS
Journal:  Proc R Soc Med       Date:  1960-06

2.  Progestational agents and their clinical uses.

Authors:  G I SWYER
Journal:  Practitioner       Date:  1959-08

3.  Treatment of functional menstrual disorders with norethisterone.

Authors:  P M BISHOP; J C CABRAL DE ALMEIDA
Journal:  Br Med J       Date:  1960-04-09

4.  Comparative activity of progestational agents on the human endometrium and vaginal epithelium of surgical castrates.

Authors:  G L WIED; M E DAVIS
Journal:  Ann N Y Acad Sci       Date:  1958-07-30       Impact factor: 5.691

5.  [The effectiveness of peroral synthetic gestagens].

Authors:  P POTS
Journal:  Zentralbl Gynakol       Date:  1957-04-06

6.  A new clinical test for the efficacy of progesterone compounds.

Authors:  R B GREENBLATT
Journal:  Am J Obstet Gynecol       Date:  1958-09       Impact factor: 8.661

7.  Delay of menstruation with norethindrone, an orally given progestational compound.

Authors:  R B GREENBLATT; E C JUNGCK
Journal:  J Am Med Assoc       Date:  1958-03-22

8.  Progestational effectiveness of 19-norethinyl-testosterone by oral route in women.

Authors:  R HERTZ; J H WAITE; L B THOMAS
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

9.  The effect of 17alpha-ethinyl-19-nortestosterone (norethisterone) on the urinary excretion of oestrogens, pregnanediol and gonadotrophins during the menstrual cycle.

Authors:  J B BROWN; K FOTHERBY; J A LORAINE
Journal:  Proc R Soc Med       Date:  1960-06
  9 in total
  2 in total

1.  [Inhibition of ovulation by gestagens and its significance in contraception].

Authors:  P Kostić
Journal:  Arch Gynakol       Date:  1965

Review 2.  Risk-benefit assessment of drugs used for the treatment of menstrual disorders.

Authors:  J M Higham; R W Shaw
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.